GIPR and pancreatic neuroendocrine tumor: GIPR was significantly higher in neuroendocrine tumors (NETs), such as functional pancreatic NETs (including insulinomas), gastrinomas, and non-functional pancreatic NETs, compared to non-neoplastic tissue [58].